Suppr超能文献

经肛门内镜显微手术(TEM)用于直肠腺瘤和“低风险”癌(uT1,G1 - 2)的微创切除。

Transanal endoscopic microsurgery (TEM) for minimally invasive resection of rectal adenomas and "Low-risk" carcinomas (uT1, G1 - 2).

作者信息

Langer C, Liersch T, Markus P, Süss M, Ghadimi M, Füzesi L, Becker H

机构信息

Department of General Surgery, Georg August University, Göttingen, Germany.

出版信息

Z Gastroenterol. 2002 Feb;40(2):67-72. doi: 10.1055/s-2002-20210.

Abstract

Transanal endoscopic microsurgery (TEM) presents a minimally invasive procedure for local removal of large rectal adenomas (>/= 2 cm) and early, so called "low-risk" carcinomas (uT1, G1 - 2) in curative as well as of advanced tumors in palliative intent. Over a 6-year period 92 TEM excisions of rectal tumors were carried out including 91 patients with 56 adenomas, 35 carcinomas (9 pTis, 17 pT1, 5 pT2, 3 pT3, 1 Ca after snare diathermy) and one neurinoma. Two patients of the carcinoma group had to be reoperated by means of anterior resection due to false preoperative rectal ultrasound examination (2 x uT1--> pT2). 4 patients required palliative therapy on account of age or high morbidity. After a mean follow-up time of 23 months (adenomas 23 months, pT1 carcinoma 26 months and advanced tumors 38 months) we encountered a total of 7 complications, of which in 5 cases surgical reintervention was necessary (5,4 %). One 86-year-old patient with a pT2-carcinoma, who was unsuitable for low anterior resection due to a high morbidity risk, died from myocardial infarction after emergency reintervention caused by postoperative bleeding. To date, overall 9 recurrences occurred (9,8 %). In the specific target group of TEM (adenomas and pT1, G1-2 carcinomas) consisting of n = 83 cases, the overall recurrence rate was 7,2 %, of which 5,3 % were due to adenomas and 11,5 % due to carcinomas. After palliative excision 2 recurrences occurred. These results of transanal endoscopic microsurgery (TEM) indicate that this technique has a useful place in curative, as well as in palliative management of rectal tumors.

摘要

经肛门内镜显微手术(TEM)是一种微创手术,可用于局部切除大型直肠腺瘤(≥2 cm)以及早期所谓的“低风险”癌(uT1,G1 - 2)以达到根治目的,也可用于切除晚期肿瘤以缓解症状。在6年的时间里,共进行了92例直肠肿瘤的TEM切除术,其中包括91例患者,有56例腺瘤、35例癌(9例pTis、17例pT1、5例pT2、3例pT3、1例圈套电切术后的癌)和1例神经鞘瘤。由于术前直肠超声检查错误,癌组中有2例患者不得不接受前切除术再次手术(2例从uT1变为pT2)。4例患者因年龄或高发病率需要姑息治疗。平均随访时间为23个月(腺瘤23个月,pT1癌26个月,晚期肿瘤38个月),我们共遇到7例并发症,其中5例需要手术再次干预(5.4%)。一名86岁的pT2癌患者因高发病风险不适合低位前切除术,在术后出血导致的紧急再次干预后死于心肌梗死。迄今为止,共发生9例复发(9.8%)。在由n = 83例病例组成的TEM特定目标组(腺瘤和pT1,G1 - 2癌)中,总复发率为7.2%,其中腺瘤导致的复发率为5.3%,癌导致的复发率为11.5%。姑息切除术后发生2例复发。经肛门内镜显微手术(TEM)的这些结果表明,该技术在直肠肿瘤的根治性治疗以及姑息性治疗中都有其应用价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验